Radiotherapy Quality Assurance for Mesorectum Treatment Planning Within the Multi-Center Phase II STAR-TReC Trial: Dutch Results

Radiation Oncology - United Kingdom
doi 10.1186/s13014-020-01487-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Method for Multi-Criteria Evaluation as the Planning Instrument to Quality Assurance Activities

Radio industry
2018English

Cytomegalovirus Vaccine: Phase II Clinical Trial Results

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2014English

Quality Assurance in the Preanalytical Phase

2011English

Treatment Planning for Charged Particle Radiotherapy

1980English

Melphalan, Lenalidomide and Dexamethasone for the Treatment of Immunoglobulin Light Chain Amyloidosis: Results of a Phase II Trial

Haematologica
Hematology
2012English

Multi-Modality Optimisation in Radiotherapy Treatment Planning Using Composite Objective Values

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2015English

Tailored Postoperative Treatment of Prostate Cancer: Final Results of a Phase I/Ii Trial

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2018English

Advanced Treatment Planning Strategies to Enhance Quality and Efficiency of Radiotherapy

Physics and Imaging in Radiation Oncology
Nuclear MedicineRadiologyRadiationImagingOncology
2019English

The Center for HIV/AIDS Vaccine Immunology (CHAVI) Multi-Site Quality Assurance Program for Cryopreserved Human Peripheral Blood Mononuclear Cells

Journal of Immunological Methods
AllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy